{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:47:39Z","timestamp":1783435659798,"version":"3.54.6"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Small Animal Practice"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cvsm.2023.05.015","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T15:52:38Z","timestamp":1688745158000},"page":"1353-1366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Beyond Angiotensin-Converting Enzyme Inhibitors"],"prefix":"10.1016","volume":"53","author":[{"given":"Marisa K.","family":"Ames","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy B.","family":"Adin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cvsm.2023.05.015_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/jvim.15662","article-title":"Role of electrolyte concentrations and renin-angiotensin-aldosterone activation in the staging of canine heart disease","volume":"34","author":"Adin","year":"2020","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.015_bib2","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/jvim.15548","article-title":"Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease","volume":"33","author":"Larouche-Lebel \u00c9","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.015_bib3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2460\/ajvr.2001.62.961","article-title":"Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs","volume":"62","author":"Tidholm","year":"2001","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.015_bib4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1939-1676.2007.tb02933.x","article-title":"Plasma big endothelin-1, atrial natriuretic peptide, aldosterone, and norepinephrine concentrations in normal Doberman Pinschers and Doberman Pinschers with dilated cardiomyopathy","volume":"21","author":"O'Sullivan","year":"2007","journal-title":"J\u00a0Vet Intern Med"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.015_bib5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1939-1676.2006.tb00707.x","article-title":"The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure","volume":"20","author":"MacDonald","year":"2006","journal-title":"J\u00a0Vet Intern Med"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.015_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2460\/ajvr.1997.58.05.535","article-title":"Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease","volume":"58","author":"Jensen","year":"1997","journal-title":"Am J Vet Res"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.015_bib7","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jvim.16401","article-title":"Circulating renin-angiotensin-aldosterone system activity in cats with systemic hypertension or cardiomyopathy","volume":"36","author":"Ward","year":"2022","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.015_bib8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jvim.16687","article-title":"The classical and alternative circulating renin-angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease","volume":"37","author":"Hammond","year":"2023","journal-title":"J\u00a0Vet Intern Med"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.015_bib9","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.015_bib10","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/157016111796642689","article-title":"Aldosterone, from (patho)physiology to treatment in cardiovascular and renal damage","volume":"9","author":"Waanders","year":"2011","journal-title":"Curr Vasc Pharmacol"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.015_bib11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.HYP.0000201443.63240.a7","article-title":"Effects of aldosterone on the vasculature","volume":"47","author":"Schiffrin","year":"2006","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.015_bib12","doi-asserted-by":"crossref","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","article-title":"Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?","volume":"310","author":"Chappell","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cvsm.2023.05.015_bib13","first-page":"34","article-title":"DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study","volume":"27","author":"Borgarelli","year":"2020","journal-title":"J\u00a0Vet Cardiol"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.015_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1939-1676.2002.tb01610.x","article-title":"Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation","volume":"16","author":"Kvart","year":"2002","journal-title":"J\u00a0Vet Intern Med"},{"issue":"7","key":"10.1016\/j.cvsm.2023.05.015_bib15","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2460\/javma.231.7.1061","article-title":"Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency","volume":"231","author":"Atkins","year":"2007","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.015_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1-7)\/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol Rev"},{"issue":"8","key":"10.1016\/j.cvsm.2023.05.015_bib17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","article-title":"Discovery and characterization of alamandine: a novel component of the renin-angiotensin system","volume":"112","author":"Lautner","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.cvsm.2023.05.015_bib18","series-title":"Textbook of nephro-endocrinology","first-page":"1","article-title":"Chapter 1: Physiology and Regulation of the Renin-Angiotensin-Aldsoterone System","author":"Carey","year":"2009"},{"issue":"7","key":"10.1016\/j.cvsm.2023.05.015_bib19","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1681\/ASN.2011121159","article-title":"Liver angiotensinogen is the primary source of renal angiotensin II","volume":"23","author":"Matsusaka","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.015_bib20","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/01.HYP.29.6.1240","article-title":"Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I","volume":"29","author":"de Lannoy","year":"1997","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.015_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1152\/physiolgenomics.1999.1.1.3","article-title":"Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice","volume":"1","author":"Davisson","year":"1999","journal-title":"Physiol Genomics"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.015_bib22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/jvim.16361","article-title":"Characterization of the intrarenal renin-angiotensin system in cats with naturally occurring chronic kidney disease","volume":"36","author":"Louren\u00e7o","year":"2022","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.015_bib23","doi-asserted-by":"crossref","first-page":"H139","DOI":"10.1152\/ajpheart.00373.2017","article-title":"The prorenin receptor in the cardiovascular system and beyond","volume":"314","author":"Hennrikus","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.015_bib24","doi-asserted-by":"crossref","first-page":"9762","DOI":"10.1038\/s41598-019-46114-x","article-title":"Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation","volume":"9","author":"Kovarik","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.cvsm.2023.05.015_bib25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2016.11.064","article-title":"Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure","volume":"69","author":"Basu","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.015_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1373\/clinchem.2017.278705","article-title":"Low- and High-renin Heart Failure Phenotypes with Clinical Implications","volume":"64","author":"Pavo","year":"2018","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.015_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/jvim.15948","article-title":"Effect of angiotensin receptor blockers and angiotensin-converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease","volume":"35","author":"Huh","year":"2021","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.015_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jvim.16589","article-title":"Influence of sex on renin-angiotensin-aldosterone system metabolites and enzymes in Doberman Pinschers","volume":"37","author":"Adin","year":"2023","journal-title":"J\u00a0Vet Intern Med"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.015_bib29","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1161\/HYPERTENSIONAHA.120.15841","article-title":"Plasma Angiotensin Peptide Profiling and ACE (Angiotensin-Converting Enzyme)-2 Activity in COVID-19 Patients Treated With Pharmacological Blockers of the Renin-Angiotensin System","volume":"76","author":"Kintscher","year":"2020","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.015_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1590\/S0066-782X2002000400012","article-title":"Alternate angiotensin II-forming pathways and their importance in physiological or physiopathological conditions","volume":"78","author":"Resende","year":"2002","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.015_bib31","first-page":"2414","article-title":"Tissue renin-angiotensin system enzyme activity in canine post-mortem myocardial and kidney samples","volume":"36","author":"Weitzhandler","year":"2022","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.015_bib32","first-page":"51","article-title":"Comparison between the effects of torsemide and furosemide on the renin-angiotensin-aldosterone system of normal dogs","volume":"26","author":"Potter","year":"2019","journal-title":"J\u00a0Vet Cardiol"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.015_bib33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1748-5827.2006.00264.x","article-title":"Measurement of aldosterone in feline, canine and human urine","volume":"48","author":"Syme","year":"2007","journal-title":"J\u00a0Small Anim Pract"},{"key":"10.1016\/j.cvsm.2023.05.015_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","article-title":"Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS","volume":"66","author":"Patel","year":"2014","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.015_bib35","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1111\/jvim.15572","article-title":"Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo-controlled clinical trial","volume":"33","author":"King","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.015_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1939-1676.1995.tb01075.x","article-title":"Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group. The COVE Study Group","volume":"9","year":"1995","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.015_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1939-1676.1995.tb01074.x","article-title":"Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study. The IMPROVE Study Group","volume":"9","year":"1995","journal-title":"J\u00a0Vet Intern Med"},{"issue":"11","key":"10.1016\/j.cvsm.2023.05.015_bib38","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2460\/javma.1998.213.11.1573","article-title":"Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group","volume":"213","author":"Ettinger","year":"1998","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.015_bib39","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1939-1676.2008.0150.x","article-title":"Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study","volume":"22","author":"H\u00e4ggstr\u00f6m","year":"2008","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.015_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5326\/0420249","article-title":"Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs","volume":"42","author":"Lombard","year":"2006","journal-title":"J\u00a0Am Anim Hosp Assoc"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.015_bib41","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/jvim.16155","article-title":"Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)","volume":"35","author":"Coffman","year":"2021","journal-title":"J\u00a0Vet Intern Med"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.015_bib42","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/jvim.15863","article-title":"Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial","volume":"34","author":"Wess","year":"2020","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.015_bib43","first-page":"218","article-title":"Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease","volume":"19","author":"Ames","year":"2017","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.015_bib44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/bs.vh.2018.10.001","article-title":"Paracrine Regulation of Aldosterone Secretion in Physiological and Pathophysiological Conditions","volume":"109","author":"Lefebvre","year":"2019","journal-title":"Vitam Horm"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.015_bib45","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/jvim.15488","article-title":"ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs","volume":"33","author":"Keene","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.015_bib46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/age.12260","article-title":"Polymorphisms in the canine and feline renin-angiotensin-aldosterone system genes","volume":"46","author":"Meurs","year":"2015","journal-title":"Anim Genet"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.015_bib47","article-title":"Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism","volume":"18","author":"Meurs","year":"2017","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.015_bib48","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/jvim.15746","article-title":"Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism","volume":"34","author":"Adin","year":"2020","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.015_bib49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40575-021-00105-2","article-title":"Prevalence of an angiotensin-converting enzyme gene variant in dogs","volume":"8","author":"Adin","year":"2021","journal-title":"Canine Med Genet"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.015_bib50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/FPC.0000000000000322","article-title":"Angiotensin-converting enzyme activity in Cavalier King Charles Spaniels with an ACE gene polymorphism and myxomatous mitral valve disease","volume":"28","author":"Meurs","year":"2018","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.015_bib51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jvim.16025","article-title":"Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease","volume":"35","author":"Larouche-Lebel \u00c9","year":"2021","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.015_bib52","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/jvim.16097","article-title":"Effect of spironolactone and benazepril on furosemide-induced diuresis and renin-angiotensin-aldosterone system activation in normal dogs","volume":"35","author":"Adin","year":"2021","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.015_bib53","article-title":"Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition","volume":"17","author":"Ames","year":"2016","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.015_bib54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.015_bib55","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-3565(25)33248-9","article-title":"Beta adrenergically mediated release of renin in the dog is not confined to either beta-1 or beta-2 adrenoceptors","volume":"222","author":"Olson","year":"1982","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.015_bib56","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1939-1676.1995.tb01092.x","article-title":"Activation of the renin-angiotensin system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency","volume":"9","author":"Pedersen","year":"1995","journal-title":"J\u00a0Vet Intern Med"},{"issue":"9","key":"10.1016\/j.cvsm.2023.05.015_bib57","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/jsap.12387","article-title":"Cardiovascular-renal axis disorders in the domestic dog and cat: a veterinary consensus statement","volume":"56","author":"Pouchelon","year":"2015","journal-title":"J\u00a0Small Anim Pract"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.015_bib58","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s10741-022-10218-w","article-title":"Cardiorenal syndrome: long road between kidney and heart","volume":"27","author":"Junho","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.015_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12917-020-02716-6","article-title":"Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease","volume":"17","author":"Galizzi","year":"2021","journal-title":"BMC Vet Res"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.015_bib60","doi-asserted-by":"crossref","first-page":"R498","DOI":"10.1152\/ajpregu.00182.2014","article-title":"Estrogen status and the renin angiotensin aldosterone system","volume":"307","author":"O'Donnell","year":"2014","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.015_bib61","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2125.2007.03091.x","article-title":"Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure","volume":"65","author":"Zakrzewski-Jakubiak","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.015_bib62","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3109\/07420528.2014.897711","article-title":"Influence of feeding schedules on the chronobiology of renin activity, urinary electrolytes and blood pressure in dogs","volume":"31","author":"Mochel","year":"2014","journal-title":"Chronobiol Int"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.015_bib63","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1939-1676.2006.tb00709.x","article-title":"Effects of dietary modification in dogs with early chronic valvular disease","volume":"20","author":"Freeman","year":"2006","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.015_bib64","unstructured":"Holbrook T, Lester G, Sleeper M, et\u00a0al. Renin-angiotensin-aldosterone system profilling in horses before and after exercise. 2021;35(6):2975-2976 (abstract)."},{"issue":"9","key":"10.1016\/j.cvsm.2023.05.015_bib65","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3109\/07420528.2013.807275","article-title":"Chronobiology of the renin-angiotensin-aldosterone system in dogs: relation to blood pressure and renal physiology","volume":"30","author":"Mochel","year":"2013","journal-title":"Chronobiol Int"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.015_bib66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00726-013-1507-z","article-title":"The effect of taurine on chronic heart failure: actions of taurine against catecholamine and angiotensin II","volume":"46","author":"Ito","year":"2014","journal-title":"Amino Acids"}],"container-title":["Veterinary Clinics of North America: Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561623000888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561623000888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:50:31Z","timestamp":1759283431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195561623000888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0195561623000888"],"URL":"https:\/\/doi.org\/10.1016\/j.cvsm.2023.05.015","relation":{},"ISSN":["0195-5616"],"issn-type":[{"value":"0195-5616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond Angiotensin-Converting Enzyme Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Small Animal Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cvsm.2023.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}